{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T06:36:03Z","timestamp":1764225363273},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T00:00:00Z","timestamp":1463443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.nefro.2016.04.007","type":"journal-article","created":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T08:56:10Z","timestamp":1473065770000},"page":"87-92","source":"Crossref","is-referenced-by-count":10,"title":["Sangrado de angiomiolipoma renal en paciente con s\u00edndrome de genes contiguos (TSC2\/PKD1) tras 17 a\u00f1os de tratamiento renal sustitutivo"],"prefix":"10.1016","volume":"37","author":[{"given":"M\u00f3nica","family":"Furlano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaima","family":"Barreiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carme","family":"Facundo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9sar","family":"Ruiz-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iara","family":"DaSilva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Ayasreh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Cabrera-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Ballar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabet","family":"Ars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roser","family":"Torra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2016.04.007_bib0120","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0272-6386(83)80044-4","article-title":"Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980","volume":"2","author":"Iglesias","year":"1983","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2016.04.007_bib0125","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/1471-2369-14-186","article-title":"Renal replacement therapy in ADPKD patients: A 25-year survey based on the Catalan registry","volume":"14","author":"Martinez","year":"2013","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.nefro.2016.04.007_bib0130","first-page":"881","article-title":"The polycystic kidney disease 1 gene encodes a 14kb transcript and lies within a duplicated region on chromosome 16","volume":"77","year":"1994","journal-title":"The European Polycystic Kidney Disease Consortium"},{"key":"10.1016\/j.nefro.2016.04.007_bib0135","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","article-title":"PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein","volume":"272","author":"Mochizuki","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.nefro.2016.04.007_bib0140","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"Van Slegtenhorst","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nefro.2016.04.007_bib0145","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nefro.2016.04.007_bib0150","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1294-328","article-title":"Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome","volume":"8","author":"Brook-Carter","year":"1994","journal-title":"Nat Genet."},{"key":"10.1016\/j.nefro.2016.04.007_bib0155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12881-015-0185-y","article-title":"Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated","volume":"16","author":"Cabrera-Lopez","year":"2015","journal-title":"BMC Med Genet."},{"key":"10.1016\/j.nefro.2016.04.007_bib0160","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0898-6568(03)00040-8","article-title":"Tumour suppressors hamartin and tuberin: Intracellular signalling","volume":"15","author":"Krymskaya","year":"2003","journal-title":"Cell Signal."},{"key":"10.1016\/j.nefro.2016.04.007_bib0165","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/MCB.01259-08","article-title":"Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1","volume":"29","author":"Distefano","year":"2009","journal-title":"Mol Cell Biol."},{"key":"10.1016\/j.nefro.2016.04.007_bib0170","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/B978-0-444-52891-9.00038-5","article-title":"Tuberous sclerosis","volume":"111","author":"Curatolo","year":"2013","journal-title":"Handb Clin Neurol."},{"key":"10.1016\/j.nefro.2016.04.007_bib0175","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/j.1523-1755.2004.00838.x","article-title":"Renal angiomyolipomata","volume":"66","author":"Bissler","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2016.04.007_bib0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/j.ajkd.2005.09.028","article-title":"Embolization of renal angiomyolipomata in patients with tuberous sclerosis complex","volume":"47","author":"Williams","year":"2006","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2016.04.007_bib0185","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1053\/ajkd.2002.32770","article-title":"Reduction of postembolization syndrome after ablation of renal angiomyolipoma","volume":"39","author":"Bissler","year":"2002","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefro.2016.04.007_bib0190","article-title":"Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: Extension of a randomized controlled trial","volume":"8","author":"Bissler","year":"2015","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2016.04.007_bib0195","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nefro.2016.04.007_bib0200","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nefro.2016.04.007_bib0205","article-title":"Volume regression of native polycystic kidneys after renal transplantation","volume":"4","author":"Jung","year":"2015","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2016.04.007_bib0210","first-page":"292","article-title":"Effects of rapamycin on angiomyolipomas in patients with tuberous sclerosis","volume":"31","author":"Cabrera","year":"2011","journal-title":"Nefrologia."},{"key":"10.1016\/j.nefro.2016.04.007_bib0215","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1750-1172-7-87","article-title":"Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: A 2years trial","volume":"7","author":"Cabrera-Lopez","year":"2012","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.nefro.2016.04.007_bib0220","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): A multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.nefro.2016.04.007_bib0225","doi-asserted-by":"crossref","first-page":"e23379","DOI":"10.1371\/journal.pone.0023379","article-title":"Multicenter phase 2 trial of sirolimus for tuberous sclerosis: Kidney angiomyolipomas and other tumors regress and other tumors regress and VEGF- D levels decrease","volume":"6","author":"Dabora","year":"2011","journal-title":"PLoS One."},{"key":"10.1016\/j.nefro.2016.04.007_bib0230","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1053\/j.ajkd.2011.10.013","article-title":"Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR inhibition","volume":"59","author":"Budde","year":"2012","journal-title":"Am J Kidney Dis."}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699516300583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699516300583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T15:58:10Z","timestamp":1536422290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699516300583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0211699516300583"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2016.04.007","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}